MAZZAFERRO, SANDRO
MAZZAFERRO, SANDRO
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
1983 Coen, Giorgio; Taccone Gallucci, M; Bonucci, Ermanno; Ballanti, Paola; Bianchi, Ar; Bianchini, Gabriella; Matteucci, Mc; Mazzaferro, Sandro; Picca, S; Taggi, F; Cinotti, Ga; Casciani, Cu
1-Alpha-OH-cholecalciferol (1-alpha-OHD3) and low phosphate diet in predialysis chronic renal failure: Effects on renal function and on secondary hyperparathyroidism
1984 Coen, Giorgio; F., Messa; C., Massimetti; Mazzaferro, Sandro; M., Manganiello; G., Donato; D., Finistauri; Giuliano G., Cinotti Ga
[Acebutolol as monotherapy of essential arterial hypertension].
1984 Mazzaferro, Sandro; G., Giuliano; M., Lucchini; G., Airoldi; D., Finistauri; C., Massimetti; F., Messa; Coen, Giorgio
[Assay of serum 24,25-dihydroxycholecalciferol by a competitive protein binding method].
1981 Coen, Giorgio; A. R., Bianchi; Ballanti, Paola; Bianchini, Gabriella; E., Bravo; Mazzaferro, Sandro; G. A., Cinotti
[Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
1989 Coen, Giorgio; L., Nazzaro; P., Cipriani; A., Giordano; Mazzaferro, Sandro; S., Petta; M. G., Reale; A., Smacchi
[Bone histomorphometry: methodological criteria in the study of metabolic skeletal diseases].
1981 Coen, Giorgio; Ballanti, Paola; M., Taccone Gallucci; A. R., Bianchi; Bianchini, Gabriella; Mazzaferro, Sandro; I., Milletti; G. A., Cinotti
[Calcium-phosphorus changes in chronic anticonvulsant therapy: effects of the administration of 25-hydroxyvitamin D3 on secondary hyperparathyroidism].
1983 Bianchini, Gabriella; Mazzaferro, Sandro; U., Mancini; A. R., Bianchi; G., Donato; C., Massimetti; M. R., Faedda; G., Sideri; Coen, Giorgio
[Circannual rhythm of plasma 25-hydroxycholecalciferol in normal man].
1980 Coen, Giorgio; Bianchini, Gabriella; Mazzaferro, Sandro; A. R., Bianchi; G., Gallucci
[CKD-MBD in Peritoneal Dialysis]
2018 Rocca, Anna Rachele; Gnerre Musto, Tania; Mazzaferro, Sandro
[Hyperphosphatemia in dialysis: which binder?]
2018 Alfieri, Carlo; Malberti, Fabio; Mazzaferro, Sandro; Gallieni, Maurizio; Russo, Domenico; Messa, Piergiorgio; Cozzolino, Mario
[Hypoparathyroidism and Addison's disease with moniliasis: report of two cases in childhood (author's transl)].
1981 Picchio, E; Coen, Giorgio; De Nardo, L; Francalancia, R; Mazzaferro, Sandro; Parolin, A.
[Optimal use of peritoneal dialysis with multi-disciplinary management].
2013 Elios G., Russo; A., Martinez; Mazzaferro, Sandro; A., Nunzi; Testorio, Massimo; A. R., Rocca; Lai, Silvia; A., Morgia; Borzacca, Barbara; T., Gnerre Musto
[Pathophysiology of secondary hyperparathyroidism: the role of FGF23 and Klotho].
2009 Mazzaferro, Sandro; Pasquali, M; Tartaglione, Lida; Rotondi, Silverio; Pirrò, G.
[Peritoneal dialysis in the Lazio region. results from 2017 regional audit]
2020 Morosetti, Massimo; Rocca, Anna Rachele; Domenici, Alessandro; D'Alonzo, Silvia; Caramiello, Stella; Filippini, Armando; Santoboni, Alberto; Palumbo, Roberto; Menè, Paolo; Mazzaferro, Sandro; Neri, Loris
[Serum 25-hydroxycholecalciferol and parathyroid function in the nephrotic syndrome].
1981 Coen, Giorgio; Bianchini, Gabriella; Mazzaferro, Sandro; Di Segni, M; Bianchi, Ar; Bravo, E; Gallucci, G; Cinotti, Ga
[Update on the pathogenesis and possible therapeutic approach to vascular calcifications in patients with chronic renal failure].
2011 Pasquali, M; Tartaglione, Lida; Rotondi, Silverio; Muci, Ml; Pirro', G; Mazzaferro, Sandro
A new technique for measuring fistula flow using venous blood gas oxygen saturation in patients with a central venous catheter
2019 Rotondi, Silverio; Tartaglione, Lida; Muci, Maria Luisa; Pasquali, Marzia; Pirozzi, Nicola; Mazzaferro, Sandro
A simple visual clots score system allows to reduce the dose of low molecular weight heparin in hemodialysis
2021 Rotondi, Silverio; Muci, Maria Luisa; Tartaglione, Lida; Carbone, Luciano; Ceravolo, Maria Josè; Mazzaferro, Sandro
Achievement of NKF/K-DOQI Recommended Target Values for Bone and Mineral Metabolism in Incident Hemodialysis Patients: Results of the FARO-2 Cohort.
2014 Cozzolino, M; Messa, P; Brancaccio, D; Cannella, G; Bolasco, P; Di Luca, M; Costanzo, Am; di Luzio Paparatti, U; Festa, V; Gualberti, G; Mazzaferro, Sandro
Adult patients affected by cystic fibrosis in therapy with cystic fibrosis transmembrane regulator modulators and lung transplant: renal function, metabolic and nutritional status
2020 Lai, Silvia; Mazzaferro, Sandro; Mitterhofer, Anna Paola; Tinti, Francesca; Bonci, Enea; Giovannetti, Antonello; Casella, Claudio; Perrotta, Adolfo Marco; Bagordo, Domenico; Murciano, Manuel; Galani, Alessandro; Celani, Camilla; Troiani, Patrizia; Cimino, Giuseppe; Palange, Paolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone. | 1983 | Coen, Giorgio; Taccone Gallucci, M; Bonucci, Ermanno; Ballanti, Paola; Bianchi, Ar; Bianchini, Gabriella; Matteucci, Mc; Mazzaferro, Sandro; Picca, S; Taggi, F; Cinotti, Ga; Casciani, Cu | |
| 1-Alpha-OH-cholecalciferol (1-alpha-OHD3) and low phosphate diet in predialysis chronic renal failure: Effects on renal function and on secondary hyperparathyroidism | 1984 | Coen, Giorgio; F., Messa; C., Massimetti; Mazzaferro, Sandro; M., Manganiello; G., Donato; D., Finistauri; Giuliano G., Cinotti Ga | |
| [Acebutolol as monotherapy of essential arterial hypertension]. | 1984 | Mazzaferro, Sandro; G., Giuliano; M., Lucchini; G., Airoldi; D., Finistauri; C., Massimetti; F., Messa; Coen, Giorgio | |
| [Assay of serum 24,25-dihydroxycholecalciferol by a competitive protein binding method]. | 1981 | Coen, Giorgio; A. R., Bianchi; Ballanti, Paola; Bianchini, Gabriella; E., Bravo; Mazzaferro, Sandro; G. A., Cinotti | |
| [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis]. | 1989 | Coen, Giorgio; L., Nazzaro; P., Cipriani; A., Giordano; Mazzaferro, Sandro; S., Petta; M. G., Reale; A., Smacchi | |
| [Bone histomorphometry: methodological criteria in the study of metabolic skeletal diseases]. | 1981 | Coen, Giorgio; Ballanti, Paola; M., Taccone Gallucci; A. R., Bianchi; Bianchini, Gabriella; Mazzaferro, Sandro; I., Milletti; G. A., Cinotti | |
| [Calcium-phosphorus changes in chronic anticonvulsant therapy: effects of the administration of 25-hydroxyvitamin D3 on secondary hyperparathyroidism]. | 1983 | Bianchini, Gabriella; Mazzaferro, Sandro; U., Mancini; A. R., Bianchi; G., Donato; C., Massimetti; M. R., Faedda; G., Sideri; Coen, Giorgio | |
| [Circannual rhythm of plasma 25-hydroxycholecalciferol in normal man]. | 1980 | Coen, Giorgio; Bianchini, Gabriella; Mazzaferro, Sandro; A. R., Bianchi; G., Gallucci | |
| [CKD-MBD in Peritoneal Dialysis] | 2018 | Rocca, Anna Rachele; Gnerre Musto, Tania; Mazzaferro, Sandro | |
| [Hyperphosphatemia in dialysis: which binder?] | 2018 | Alfieri, Carlo; Malberti, Fabio; Mazzaferro, Sandro; Gallieni, Maurizio; Russo, Domenico; Messa, Piergiorgio; Cozzolino, Mario | |
| [Hypoparathyroidism and Addison's disease with moniliasis: report of two cases in childhood (author's transl)]. | 1981 | Picchio, E; Coen, Giorgio; De Nardo, L; Francalancia, R; Mazzaferro, Sandro; Parolin, A. | |
| [Optimal use of peritoneal dialysis with multi-disciplinary management]. | 2013 | Elios G., Russo; A., Martinez; Mazzaferro, Sandro; A., Nunzi; Testorio, Massimo; A. R., Rocca; Lai, Silvia; A., Morgia; Borzacca, Barbara; T., Gnerre Musto | |
| [Pathophysiology of secondary hyperparathyroidism: the role of FGF23 and Klotho]. | 2009 | Mazzaferro, Sandro; Pasquali, M; Tartaglione, Lida; Rotondi, Silverio; Pirrò, G. | |
| [Peritoneal dialysis in the Lazio region. results from 2017 regional audit] | 2020 | Morosetti, Massimo; Rocca, Anna Rachele; Domenici, Alessandro; D'Alonzo, Silvia; Caramiello, Stella; Filippini, Armando; Santoboni, Alberto; Palumbo, Roberto; Menè, Paolo; Mazzaferro, Sandro; Neri, Loris | |
| [Serum 25-hydroxycholecalciferol and parathyroid function in the nephrotic syndrome]. | 1981 | Coen, Giorgio; Bianchini, Gabriella; Mazzaferro, Sandro; Di Segni, M; Bianchi, Ar; Bravo, E; Gallucci, G; Cinotti, Ga | |
| [Update on the pathogenesis and possible therapeutic approach to vascular calcifications in patients with chronic renal failure]. | 2011 | Pasquali, M; Tartaglione, Lida; Rotondi, Silverio; Muci, Ml; Pirro', G; Mazzaferro, Sandro | |
| A new technique for measuring fistula flow using venous blood gas oxygen saturation in patients with a central venous catheter | 2019 | Rotondi, Silverio; Tartaglione, Lida; Muci, Maria Luisa; Pasquali, Marzia; Pirozzi, Nicola; Mazzaferro, Sandro | |
| A simple visual clots score system allows to reduce the dose of low molecular weight heparin in hemodialysis | 2021 | Rotondi, Silverio; Muci, Maria Luisa; Tartaglione, Lida; Carbone, Luciano; Ceravolo, Maria Josè; Mazzaferro, Sandro | |
| Achievement of NKF/K-DOQI Recommended Target Values for Bone and Mineral Metabolism in Incident Hemodialysis Patients: Results of the FARO-2 Cohort. | 2014 | Cozzolino, M; Messa, P; Brancaccio, D; Cannella, G; Bolasco, P; Di Luca, M; Costanzo, Am; di Luzio Paparatti, U; Festa, V; Gualberti, G; Mazzaferro, Sandro | |
| Adult patients affected by cystic fibrosis in therapy with cystic fibrosis transmembrane regulator modulators and lung transplant: renal function, metabolic and nutritional status | 2020 | Lai, Silvia; Mazzaferro, Sandro; Mitterhofer, Anna Paola; Tinti, Francesca; Bonci, Enea; Giovannetti, Antonello; Casella, Claudio; Perrotta, Adolfo Marco; Bagordo, Domenico; Murciano, Manuel; Galani, Alessandro; Celani, Camilla; Troiani, Patrizia; Cimino, Giuseppe; Palange, Paolo |